As shown in our results, Bcl-2 and Bax mRNA were notably upregulated and downregulated, respectively, in the bladder of rats with BPH, but a high dosage of QTC reversed these changes and simultaneously improved the Bcl-2/Bax ratio imbalance. This evidence concerns the gene BCL2 and benign prostatic hyperplasia.